Please assess the completion status of the following clinical trial:

Trial Title: Gcsf Injection in Women With Repeated Implantaiton Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women between the ages of 18 and 37~* Indication of the Antagonist IVF protocol or indication of a substituted frozen embryo transfer~* Subjects with repetitive embryo implantation failure meaning: a history of 3 embryos transferred including frozen embryo without a positive pregnancy test for women 35 years and younger~* Subjects with repetitive embryo implantation failure meaning: a history of 4 embryos transferred including frozen embryo without a positive pregnancy test for women between the ages of 35 and 37.~* Negative repetitive implantation failure work up~Exclusion Criteria:~* Renal failure or cardiac failure~* Chronic neutropenia~* Past or present cancer history~* Sickle cell anemia~* Lithium treatment~* Voluntary withdrawal from the study~* Use of concomitant medication: DHEA (dehydroepiandrosterone ), CoQ10 (coenzyme Q10), Growth Hormone and Viagra

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 37 Years
- Healthy Volunteers: f

Study Arms:
- Filgrastim (Type: ACTIVE_COMPARATOR): Injection Filgrastim 300 ug intravaginally during an IVF cycle or during an embryo transfer
- Sodium Chloride (Type: PLACEBO_COMPARATOR): Injection of 1 ml of Sodium Chloride intravaginally during an IVF cycle or during an embryo transfer cycle.

Based on this trial design, predict the completion outcome and termination type (if applicable).